Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143


The impact of botulinum toxin A and abduction bracing on long-term hip development in children with cerebral palsy.

Willoughby K, Ang SG, Thomason P, Graham HK.

Dev Med Child Neurol. 2012 Aug;54(8):743-7. doi: 10.1111/j.1469-8749.2012.04340.x. Epub 2012 Jun 12.


The impact of complementary and alternative medicine on hip development in children with cerebral palsy.

Willoughby K, Jachno K, Ang SG, Thomason P, Graham HK.

Dev Med Child Neurol. 2013 May;55(5):472-9. doi: 10.1111/dmcn.12094. Epub 2013 Feb 22.


Does botulinum toxin a combined with bracing prevent hip displacement in children with cerebral palsy and "hips at risk"? A randomized, controlled trial.

Graham HK, Boyd R, Carlin JB, Dobson F, Lowe K, Nattrass G, Thomason P, Wolfe R, Reddihough D.

J Bone Joint Surg Am. 2008 Jan;90(1):23-33. doi: 10.2106/JBJS.F.01416.


The effect of botulinum toxin type A and a variable hip abduction orthosis on gross motor function: a randomized controlled trial.

Boyd RN, Dobson F, Parrott J, Love S, Oates J, Larson A, Burchall G, Chondros P, Carlin J, Nattrass G, Graham HK.

Eur J Neurol. 2001 Nov;8 Suppl 5:109-19.


The role of botulinum toxin A and abduction bracing in the management of hip development in children with cerebral palsy.

Theologis T.

Dev Med Child Neurol. 2012 Aug;54(8):681. doi: 10.1111/j.1469-8749.2012.04335.x. Epub 2012 Jun 12. No abstract available.


Botulinum toxin A for nonambulatory children with cerebral palsy: a double blind randomized controlled trial.

Copeland L, Edwards P, Thorley M, Donaghey S, Gascoigne-Pees L, Kentish M, Cert G, Lindsley J, McLennan K, Sakzewski L, Boyd RN.

J Pediatr. 2014 Jul;165(1):140-146.e4. doi: 10.1016/j.jpeds.2014.01.050. Epub 2014 Mar 12.


Evaluation of the effects of botulinum toxin A injections when used to improve ease of care and comfort in children with cerebral palsy whom are non-ambulant: a double blind randomized controlled trial.

Thorley M, Donaghey S, Edwards P, Copeland L, Kentish M, McLennan K, Lindsley J, Gascoigne-Pees L, Sakzewski L, Boyd RN.

BMC Pediatr. 2012 Aug 9;12:120. doi: 10.1186/1471-2431-12-120.


Effects of the standing program with hip abduction on hip acetabular development in children with spastic diplegia cerebral palsy.

Macias-Merlo L, Bagur-Calafat C, Girabent-Farrés M, A Stuberg W.

Disabil Rehabil. 2016;38(11):1075-81. doi: 10.3109/09638288.2015.1100221. Epub 2015 Oct 30.


Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.

Williams SA, Elliott C, Valentine J, Gubbay A, Shipman P, Reid S.

Disabil Rehabil. 2013 Apr;35(7):596-605. doi: 10.3109/09638288.2012.711898. Epub 2012 Aug 28.


Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.

Lundy CT, Doherty GM, Fairhurst CB.

Dev Med Child Neurol. 2009 Sep;51(9):705-10. doi: 10.1111/j.1469-8749.2009.03315.x. Epub 2009 Apr 21.


[Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].

Deleplanque B, Lagueny A, Flurin V, Arnaud C, Pedespan JM, Fontan D, Pontallier JR.

Rev Chir Orthop Reparatrice Appar Mot. 2002 May;88(3):279-85. French.


Botulinum toxin A injections and occupational therapy in children with unilateral spastic cerebral palsy: a randomized controlled trial.

Lidman G, Nachemson A, Peny-Dahlstrand M, Himmelmann K.

Dev Med Child Neurol. 2015 Aug;57(8):754-61. doi: 10.1111/dmcn.12739. Epub 2015 Mar 22.


Should botulinum toxin A injections be repeated in children with cerebral palsy? A systematic review.

Kahraman A, Seyhan K, Değer Ü, Kutlutürk S, Mutlu A.

Dev Med Child Neurol. 2016 Sep;58(9):910-7. doi: 10.1111/dmcn.13135. Epub 2016 Apr 22. Review.


Determinants of responsiveness to botulinum toxin, casting, and bracing in the treatment of spastic equinus in children with cerebral palsy.

Yap R, Majnemer A, Benaroch T, Cantin MA.

Dev Med Child Neurol. 2010 Feb;52(2):186-93. doi: 10.1111/j.1469-8749.2009.03365.x.


Varus derotation osteotomy for the treatment of hip subluxation and dislocation in GMFCS level III to V patients with unilateral hip involvement. Follow-up at skeletal maturity.

Canavese F, Emara K, Sembrano JN, Bialik V, Aiona MD, Sussman MD.

J Pediatr Orthop. 2010 Jun;30(4):357-64. doi: 10.1097/BPO.0b013e3181d8fbc1.


Intensive therapy following upper limb botulinum toxin A injection in young children with unilateral cerebral palsy: a randomized trial.

Hoare B, Imms C, Villanueva E, Rawicki HB, Matyas T, Carey L.

Dev Med Child Neurol. 2013 Mar;55(3):238-47. doi: 10.1111/dmcn.12054. Epub 2012 Dec 12.


The WE-Study: does botulinum toxin A make walking easier in children with cerebral palsy?: Study protocol for a randomized controlled trial.

Brændvik SM, Roeleveld K, Andersen GL, Raftemo AE, Ramstad K, Majkic-Tajsic J, Lamvik T, Lund B, Follestad T, Vik T.

Trials. 2017 Feb 6;18(1):58. doi: 10.1186/s13063-016-1772-8.


Hip lateralisation in children with bilateral spastic cerebral palsy treated with botulinum toxin type A: a 2-year follow-up.

Jung NH, Heinen F, Westhoff B, Doederlein L, Reissig A, Berweck S, Linder-Lucht M, Schandelmaier S, Mall V; German Abo study group.

Neuropediatrics. 2011 Feb;42(1):18-23. doi: 10.1055/s-0031-1275344. Epub 2011 Apr 15.


Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses.

Basciani M, Di Rienzo F, Fontana A, Copetti M, Pellegrini F, Intiso D.

Dev Med Child Neurol. 2011 Jun;53(6):559-64. doi: 10.1111/j.1469-8749.2011.03952.x. Epub 2011 Mar 17.


Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE).

Hoare BJ, Wallen MA, Imms C, Villanueva E, Rawicki HB, Carey L.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003469. doi: 10.1002/14651858.CD003469.pub4. Review.


Supplemental Content

Support Center